CLINICAL ROLE -
July 23rd 2025
June 18th 2025
Lenacapavir becomes the first and only twice-yearly option for HIV prevention.
March 20th 2025
As HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.
March 17th 2025
Data from conference abstracts and presentations indicate that both preexposure prophylaxis methods continue to demonstrate efficacy.
January 9th 2025
Pharmacists' accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.
HIV PrEP Can Be Effective Post-Exposure
Many patients wait until after becoming infected with HIV to seek treatment.
Read More
Atazanavir Not Found to Increase Cardiovascular Event Risk in HIV Patients
Patients with HIV previously believed to face an increased risk of cardiovascular disease.
'Shock and Kill' Technique Targets Hidden HIV Cells
Attacking dormant HIV cells shows promise eradicating disease.
Disparities in HIV PrEP Use Among Gay and Bisexual Men
Less than 10% of young gay, bisexual, and other men who have sex with men have used HIV pre-exposure prophylaxis.
Determining the Optimal HIV Treatment Intervention
HIV Test-and-Treat initiates antiretroviral therapy promptly, but may be too expensive to employ nationwide.
Dual Treatment Could Reduce HIV Transmission in Couples
Transmission rates reduced 96% among couples who both received treatment.
Does PrEP Induce Drug Resistance?
Resistance development has been minimal under the controlled high adherence conditions of clinical trials. However, real-world adherence is less consistent.
On-Demand Pre-Exposure Prophylaxis Drastically Reduces HIV Risk
Treatment with Truvada highly effective in reducing the risk of HIV.
Markers of Adherence in HIV Preventative Medications
Adherence to oral PrEP combined with coordinated counseling found to improve HIV therapy.
The Role of Rectal PrEP
New study results suggest tenofovir rectal gel is a safe method for preventing HIV transmission.
HIV Epidemic Continues to Surge in Some Populations
HIV infection rate among gay and bisexual men remains a problem.
Topical Antiretroviral Drug Combination Blocks HIV Transmission
Tenofovir disoproxil fumarate and emtricitabine administered via a sustained release intravaginal ring shows promise treating (S)HIV.
Primary Care Provider Attitudes Toward HIV PrEP
Novel prevention methods can help reduce the 45,000 new cases of HIV that occur in the United States annually.
Why Injection Drug Users Hesitate to Use PrEP for HIV Prevention
Those who are HIV-negative but have risk factors for HIV can take pre-exposure prophylaxis with antiretroviral medications to protect themselves.
Pharmacists Should Watch for Medication Sharing Among HIV Patients
Patients who enroll in studies, including those for pre-exposure prophylaxis, may share their medication with friends and family who have health concerns of their own or the same diagnoses.
HIV PrEP Program for Injection Drug Users Proven Costly
An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.
New Formulation of HIV Drug May Improve Long-Term Protection
Raltegravir in long-acting formulation may only be needed every month in HIV patients.
4 Findings From a Successful HIV PrEP Program
An HIV pre-exposure prophylaxis program piloted at a pharmacy in Seattle shows promising results for patients.
Does On-Demand PrEP Prevent HIV?
On-demand PrEP before and after sexual activity could reduce the incidence of HIV-1 in men who have sex with men.
How Pharmacists Can Help Address HIV Infection
The public fear of human immunodeficiency virus has diminished since the 1980s crisis, and now many health care professionals are seeing less urgency surrounding HIV prevention and treatment.
Prescribers Hesitate on HIV PrEP
While health care providers generally favor pre-exposure prophylaxis (PrEP) for patients at high risk of acquiring human immunodeficiency virus (HIV), many hesitate to actually prescribe it.
Providers Hesitant to Prescribe Pre-Exposure HIV Preventative Regimen
HIV antiviral therapy can prevent infection from establishing in at-risk individuals.
In Indiana HIV Outbreak, Pharmacists Spearhead Disease Education
The pharmacist's role as a disease educator is moving to the forefront.
Analysis of Pharmacy Data Reveals Cost Increase in HIV Medications
There have been significant increases in the cost of antiretroviral therapies (ART) for individual therapies and in the cost of therapy initiation over the past several years.
Timely Topics in HIV
The latest advances in HIV treatment and care include new drug therapies, a new at-home test, and updates guidelines for antiretroviral therapy for pregnant women.
Truvada Retains Potent Protective Element Despite Variations in Patient Adherence
Patients taking Truvada may still significantly reduce their risk of HIV infection even when they are not 100% adherent to their drug regimens, a new study revealed.
FDA Approves Truvada for HIV Risk Reduction
The FDA approved Truvada for preexposure prophylaxis, making it the first agent ever to be approved for HIV prevention in uninfected adults.
